{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:21:36Z","timestamp":1767651696127,"version":"3.40.4"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1097\/wco.0000000000000098","type":"journal-article","created":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T15:27:21Z","timestamp":1398180441000},"page":"300-308","source":"Crossref","is-referenced-by-count":10,"title":["An update on neuro-ophthalmology of multiple sclerosis"],"prefix":"10.1097","volume":"27","author":[{"given":"Sara S.","family":"Qureshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin C.","family":"Beh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa C.","family":"Frohman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot M.","family":"Frohman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210206","first-page":"554","article-title":"Histologie de la sclerose en plaques. Gazette des hopitaux.","volume":"41","author":"Charcot","year":"1868","journal-title":"Paris"},{"key":"R2-8-20210206","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10072-009-0161-4","article-title":"The first case history of multiple sclerosis: Augustus dEste (1794-1848).","volume":"31","author":"Landtblom","year":"2010","journal-title":"Neurol Sci"},{"key":"R3-8-20210206","first-page":"277","article-title":"The history of multiple sclerosis: the changing frame of the disease over the centuries.","volume":"1","author":"Murray","year":"2009","journal-title":"J Neurol Sci"},{"key":"R4-8-20210206","first-page":"1409","article-title":"Eye disorders in patients with multiple sclerosis: natural history and management.","volume":"4","author":"Graves","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"R5-8-20210206","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.ajo.2005.01.031","article-title":"Evolving management of optic neuritis and multiple sclerosis.","volume":"139","author":"Arnold","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R6-8-20210206","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/jnnp.55.9.747","article-title":"The ocular manifestations of multiple sclerosis I: abnormalities of the afferent visual system.","volume":"55","author":"McDonald","year":"1992","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"R7-8-20210206","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/09273940490895344","article-title":"Mutiple sclerosis-associated uveitis.","volume":"12","author":"Zein","year":"2004","journal-title":"Ocul Immunol Inflamm"},{"key":"R8-8-20210206","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1474-4422(05)00992-0","article-title":"Neuroophthalmology of multiple sclerosis.","volume":"4","author":"Frohman","year":"2005","journal-title":"Lancet Neurol"},{"key":"R10-8-20210206","first-page":"122","article-title":"The neuro-ophthalmology of multiple sclerosis.","volume":"16","author":"Frohman","year":"2010","journal-title":"Continuum (Minneap Minn)"},{"key":"R11-8-20210206","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1212\/WNL.54.9.1720","article-title":"Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.","volume":"54","author":"Gronseth","year":"2000","journal-title":"Neurology"},{"key":"R12-8-20210206","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10633-008-9147-4","article-title":"Multifocal VEP and OCT in optic neuritis: a topographical study of the structure-function relationship.","volume":"118","author":"Klistorner","year":"2009","journal-title":"Doc Ophthalmol"},{"key":"R13-8-20210206","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1167\/iovs.09-4577","article-title":"Interrelationship of optical coherence tomography and multifocal visual-evoked potentials after optic neuritis.","volume":"51","author":"Klistorner","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R14-8-20210206","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1212\/WNL.0b013e3181c3fd43","article-title":"Evaluation of optic neuropathy in multiple sclerosis using low-contrast visual evoked potentials.","volume":"73","author":"Thurtell","year":"2009","journal-title":"Neurology"},{"key":"R15-8-20210206","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1212\/WNL.0b013e3182661edc","article-title":"Multifocal visual evoked potentials are influenced by variable contrast stimulation in MS.","volume":"79","author":"Frohman","year":"2012","journal-title":"Neurology"},{"key":"R16-8-20210206","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/WNL.0b013e31829e6faa","article-title":"Optic nerve head component responses of the multifocal electroretinogram in MS.","volume":"81","author":"Frohman","year":"2013","journal-title":"Neurology"},{"key":"R17-8-20210206","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00041327-199703000-00004","article-title":"Visual symptoms after optic neuritis. Results from the Optic Neuritis Treatment Trial.","volume":"17","author":"Cleary","year":"1997","journal-title":"J Neuroophthalmol"},{"key":"R18-8-20210206","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000154521.40686.63","article-title":"Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis.","volume":"64","author":"Baier","year":"2005","journal-title":"Neurology"},{"key":"R19-8-20210206","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ophtha.2005.10.040","article-title":"Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis.","volume":"113","author":"Fisher","year":"2006","journal-title":"Ophthalmology"},{"key":"R20-8-20210206","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ana.22005","article-title":"Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis.","volume":"67","author":"Talman","year":"2010","journal-title":"Ann Neurol"},{"key":"R21-8-20210206","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archneurol.2009.230","article-title":"Macular volume by optical coherence tomography as a measure of neuronal loss in multiple sclerosis.","volume":"66","author":"Burkholder","year":"2009","journal-title":"Arch Neurol"},{"key":"R22-8-20210206","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1212\/01.wnl.0000278387.15090.5a","article-title":"Relation of vision to global and regional brain MRI in multiple sclerosis.","volume":"69","author":"Wu","year":"2007","journal-title":"Neurology"},{"key":"R23-8-20210206","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1191\/1352458503ms935rr","article-title":"Pattern reversal visual evoked potentials as a measure of visual pathway pathology in multiple sclerosis.","volume":"9","author":"Weinstock-Guttman","year":"2003","journal-title":"Mult Scler"},{"key":"R24-8-20210206","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jns.2012.03.009","article-title":"Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS.","volume":"318","author":"Balcer","year":"2012","journal-title":"J Neurol Sci"},{"key":"R25-8-20210206","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1177\/1352458513475722","article-title":"Alemtuzumab improves contrast sensitivity in patients with relapsing-remitting multiple sclerosis.","volume":"19","author":"Graves","year":"2013","journal-title":"Mult Scler"},{"key":"R26-8-20210206","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s00415-012-6466-x","article-title":"In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques.","volume":"259","author":"Seigo","year":"2012","journal-title":"J Neurol"},{"key":"R27-8-20210206","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/brain\/awr264","article-title":"Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis.","volume":"135","author":"Syc","year":"2012","journal-title":"Brain"},{"key":"R28-8-20210206","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.ophtha.2011.11.032","article-title":"Ganglion cell loss in relation to visual disability in multiple sclerosis.","volume":"119","author":"Walter","year":"2012","journal-title":"Ophthalmology"},{"key":"R29-8-20210206","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1212\/WNL.0b013e31827b1a1c","article-title":"Active MS is associated with accelerated retinal ganglion cellinner plexiform layer thinning.","volume":"80","author":"Ratchford","year":"2013","journal-title":"Neurology"},{"key":"R30-8-20210206","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/jamaneurol.2013.573","article-title":"Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.","volume":"70","author":"Saidha","year":"2013","journal-title":"JAMA Neurol"},{"key":"R31-8-20210206","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1167\/iovs.11-9339","article-title":"Scanning laser polarimetry reveals status of RNFL integrity in eyes with optic nerve head swelling by OCT.","volume":"53","author":"Kupersmith","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R32-8-20210206","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/archneur.65.7.924","article-title":"Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.","volume":"65","author":"Zaveri","year":"2008","journal-title":"Arch Neurol"},{"key":"R33-8-20210206","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1177\/1352458513485149","article-title":"Predictive value of 1 month retinal nerve fiber layer thinning for deficits at 6 months after acute optic neuritis.","volume":"19","author":"Kupersmith","year":"2013","journal-title":"Mult Scler"},{"key":"R34-8-20210206","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1212\/WNL.0b013e31827b1b6c","article-title":"Neurodegeneration and inflammation in MS: the eye teaches us about the storm.","volume":"80","author":"Bermel","year":"2013","journal-title":"Neurology"},{"key":"R35-8-20210206","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1212\/WNL.0b013e31827b1a1c","article-title":"Active MS is associated with accelerated retinal ganglion cellinner plexiform layer thinning.","volume":"80","author":"Ratchford","year":"2013","journal-title":"Neurology"},{"key":"R36-8-20210206","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/brain\/awr264","article-title":"Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis.","volume":"135","author":"Syc","year":"2011","journal-title":"Brain"},{"key":"R37-8-20210206","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S1474-4422(12)70213-2","article-title":"Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.","volume":"11","author":"Saidha","year":"2012","journal-title":"Lancet Neurol"},{"key":"R38-8-20210206","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12647","article-title":"A regenerative approach to the treatment of multiple sclerosis.","volume":"502","author":"Deshmukh","year":"2013","journal-title":"Nature"},{"key":"R39-8-20210206","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0140-6736(09)60442-6","article-title":"Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial.","volume":"373","author":"Goodman","year":"2009","journal-title":"Lancet"},{"key":"R40-8-20210206","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrneurol.2013.98","article-title":"Uhthoffs phenomena in MS: clinical features and pathophysiology.","volume":"9","author":"Frohman","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"R41-8-20210206","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1152\/japplphysiol.00460.2010","article-title":"Thermoregulation in multiple sclerosis.","volume":"109","author":"Davis","year":"2010","journal-title":"J Appl Physiol"},{"key":"R42-8-20210206","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1749-6632.2011.06125.x","article-title":"Modeling the mechanisms of Uhthoffs phenomenon in multiple sclerosis patients with internuclear ophthalmoparesis.","volume":"1233","author":"Frohman","year":"2011","journal-title":"Ann NY Acad Sci"},{"key":"R43-8-20210206","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1212\/WNL.0b013e3182929fd5","article-title":"Effect of 4-aminopyridine on vision in multiple sclerosis patients with optic neuropathy.","volume":"80","author":"Horton","year":"2013","journal-title":"Neurology"},{"key":"R44-8-20210206","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1212\/01.WNL.0000078893.41040.56","article-title":"Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.","volume":"61","author":"Strupp","year":"2004","journal-title":"Neurology"},{"key":"R45-8-20210206","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1212\/01.WNL.0000118287.68294.E5","article-title":"4-Aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain.","volume":"62","author":"Kalla","year":"2004","journal-title":"Neurology"},{"key":"R46-8-20210206","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0022-3565(24)38803-2","article-title":"Modulation of recombinant small-conductance Ca(2)-activated K() channels by the muscle relaxant chlorzoxazone and structurally related compounds.","volume":"296","author":"Cao","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"R47-8-20210206","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpainsymman.2004.05.002","article-title":"Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review.","volume":"28","author":"Chou","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"R48-8-20210206","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1212\/WNL.0b013e3182a55f6d","article-title":"Effect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial.","volume":"81","author":"Feil","year":"2013","journal-title":"Neurology"},{"key":"R49-8-20210206","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1136\/jnnp-2012-304736","article-title":"A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus--effects on slowphase eye velocity, postural stability, locomotion and symptoms.","volume":"84","author":"Claassen","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R50-8-20210206","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2147\/OPTH.S28112","article-title":"Current options for the treatment of optic neuritis.","volume":"6","author":"Pula","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"R51-8-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.56.1.1","article-title":"Targeting melanocortin receptors as a novel strategy to control inflammation.","volume":"56","author":"Catania","year":"2004","journal-title":"Pharmacol Rev"},{"key":"R52-8-20210206","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1742-2094-9-80","article-title":"Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis.","volume":"9","author":"Koziolek","year":"2012","journal-title":"J Neuroinflammation"},{"key":"R53-8-20210206","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000224630","article-title":"Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis.","volume":"28","author":"Trebst","year":"2009","journal-title":"Blood Purif"},{"key":"R54-8-20210206","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0404.2011.01612.x","article-title":"Treatment of steroid-unresponsive optic neuritis with plasma exchange.","volume":"126","author":"Roesner","year":"2012","journal-title":"Acta Neurol Scand"}],"container-title":["Current Opinion in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WCO.0000000000000098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T14:21:02Z","timestamp":1746195662000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00019052-201406000-00008"}},"subtitle":["the visual system as a model to study multiple sclerosis"],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/wco.0000000000000098","relation":{},"ISSN":["1350-7540"],"issn-type":[{"type":"print","value":"1350-7540"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}